Viral and latent reservoir persistence in HIV-1-infected patients on therapy
about
Modeling the within-host dynamics of HIV infectionThe transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3The immunological synapse: the gateway to the HIV reservoirA stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patientsHIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationA comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection.Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART.Modeling the dynamics and migratory pathways of virus-specific antibody-secreting cell populations in primary influenza infectionImmune activation and HIV persistence: implications for curative approaches to HIV infection.An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1.Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.Post-treatment control of HIV infection.Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells.Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population.Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infectionUnintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.Effect of the Latent Reservoir on the Evolution of HIV at the Within- and Between-Host Levels.Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study.Contribution of follicular dendritic cells to persistent HIV viremia.On the role of resonance in drug failure under HIV treatment interruption.Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips.Modeling HIV persistence, the latent reservoir, and viral blips.The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation.Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy.An HIV model with age-structured latently infected cells.Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy.The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophagesProgressive contraction of the latent HIV reservoir around a core of less-differentiated CD4⁺ memory T Cells.The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over timeExpansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.Mathematical Models of HIV Latency.Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling
P2860
Q21245370-F65125C6-5CE8-423E-A42F-4D7361DF6C4BQ24336528-8380192A-9890-4EDA-AE5A-56B669CB19C0Q27002959-6AE04003-B86C-42B5-896C-D463FAEF4ADFQ28477926-C8C8EF76-0B1C-42C9-BD0A-9A292F248D5FQ29619611-D6C31B5A-6B3C-4499-8D14-487C9DB1B242Q30596957-30E2FBEA-D70E-4EF3-8286-2241C9AF007BQ33313038-730C76C6-DE63-404B-BE5A-559179E81C7AQ33510903-7FB0678A-D3A0-4471-8AD3-241FB60064FFQ33892114-3F8BBD17-268B-41CB-BC8E-B4C464BAB466Q34109651-0DBC214B-3C46-48A0-9B0D-9A3602C0D901Q34351320-5DC5E629-B61F-4DDA-8AF7-C07701E44308Q34499103-B9B8FAD0-2C7B-4FBE-AF9A-44B7ECDA9B42Q34572554-FE14B50E-DF9A-4B06-B2D7-14290680C89EQ35567047-E5229446-6541-4DAA-8607-F86562C57157Q35819184-139FD478-3FB0-4CA8-BC7C-B7C45BE18698Q35875253-D9EB71B3-1FAA-489F-9325-AAAA905200F3Q36066494-93AE87EB-C90F-4589-A80A-90BBE9365B4FQ36102514-D660D30C-E2AA-481E-9D5F-A853EF0E62ACQ36253793-380E1752-A671-4A3A-9636-E10A68D6A464Q36900555-45ACB27E-6D3C-4F27-B1B1-51CB3B9964A6Q36978662-C28EABA4-12FB-4D42-BEFF-B8A98BE8406DQ37033475-E892979C-8D8A-49DC-A468-990C321C6D06Q37133236-D938B999-AFDA-4C82-A6F2-3915005BEE5BQ37365718-5500475F-3A92-48EE-931D-E70629176134Q37424899-523F1DE7-835F-446D-B688-F562FC4D4EEDQ37644561-18AD20D4-D01C-4099-A72B-D688F78CC4D4Q39521847-5FF03496-D001-4D3E-B726-DF007C3EDA33Q40638814-9B2532F9-14E8-4E2E-9AAC-D58668B4B500Q40775465-D6C9B710-3BA8-45F3-AF8B-B1E8E7D94B7DQ41308451-9DAF19DA-84CB-488D-BCFE-72DDC73258F7Q41670052-02055738-6D3F-412B-A948-E6A0B12E00D5Q41954397-5806F0D2-9D62-4931-B045-83C189484B98Q44127311-C00922A8-5DE7-470F-A4E3-01336374DE4CQ47574091-3A039937-82BE-458B-BC5B-DCB16AC8C794Q56000943-B5C871A5-0159-4002-85DC-0A26B916E4C9
P2860
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@ast
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@en
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@nl
type
label
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@ast
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@en
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@nl
prefLabel
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@ast
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@en
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@nl
P2860
P3181
P1476
Viral and latent reservoir persistence in HIV-1-infected patients on therapy
@en
P2093
Hwijin Kim
P2860
P3181
P356
10.1371/JOURNAL.PCBI.0020135
P407
P577
2006-10-01T00:00:00Z